ID
45772
Descrizione
Principal Investigator: Stephen Chanock, National Cancer Institute, National Health Institute, Bethesda, MD, USA MeSH: Neoplasm https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs001112 This study investigates methylation patterns in promoter regions on the X chromosomes of females with X chromosome mosaicism in an effort to phase mosaic events to either the active or inactive X chromosome.
collegamento
Keywords
versioni (1)
- 19/06/23 19/06/23 - Chiara Middel
Titolare del copyright
Stephen Chanock, National Cancer Institute, National Health Institute, Bethesda, MD, USA
Caricato su
19 giugno 2023
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs001112 Chromosome X Mosaicism Methylation Study
Subject ID and consent group of participants involved in the "Chromosome X Mosaicism Methylation Study" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants involved in the "Chromosome X Mosaicism Methylation Study" project.
- Subject ID, sample ID, and sample use of participants involved in the "Chromosome X Mosaicism Methylation Study" project.
- Subject ID, gender, phenotype of participants, and copy state (mosaic type) of participant [Gain, Loss, Neutral] and involved in the "Chromosome X Mosaicism Methylation Study" project.
- Sample ID, body site where sample was obtained, analyte type [DNA], histological type of sample, and tumor status of participants involved in the "Chromosome X Mosaicism Methylation Study" project.
Similar models
Subject ID and consent group of participants involved in the "Chromosome X Mosaicism Methylation Study" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID and consent group of participants involved in the "Chromosome X Mosaicism Methylation Study" project.
- Subject ID, sample ID, and sample use of participants involved in the "Chromosome X Mosaicism Methylation Study" project.
- Subject ID, gender, phenotype of participants, and copy state (mosaic type) of participant [Gain, Loss, Neutral] and involved in the "Chromosome X Mosaicism Methylation Study" project.
- Sample ID, body site where sample was obtained, analyte type [DNA], histological type of sample, and tumor status of participants involved in the "Chromosome X Mosaicism Methylation Study" project.